Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H24N2.C3H6O3 |
Molecular Weight | 370.4852 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)C(O)=O.CN1CCC(CC1)N(CC2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=VUNFQOFEWHEROV-UHFFFAOYSA-N
InChI=1S/C19H24N2.C3H6O3/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17;1-2(4)3(5)6/h2-11,19H,12-16H2,1H3;2,4H,1H3,(H,5,6)
Bamipine (trade name Soventol) is a sedating antihistamine with pronounced sedative effects. Bamipine is a pharmaceutical drug acting as an H1 antihistamine with anticholinergic properties. It is used as an antipruritic ointment. Bamipine hydrochloride has been given by mouth. Bamipine, bamipine lactate, and bamipine salicylate have all been applied topically.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.mims.com/india/drug/info/bamipine?type=full&mtype=generic http://www.medindia.net/doctors/drug_information/bamipine.htm
Curator's Comment: Can be used topically: A thin layer applied on the surface of the skin. Re-application is possible in 30 min. Duration of treatment depends on allergic process. http://www.druginfosys.com/drug.aspx?drugcode=1567&type=1
The recommended dose is 50-100 mg 3-4 times/day.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18977145
Bamipine treatment resulted in 29% of inhibition of Mycobacterium tuberculosis H37Rv (after 4 days by microplate alamar blue assay) at 6.25 ug/mL.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000084971
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
262-887-2
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
C020867
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
SUB00663MIG
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
236530
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | RxNorm | ||
|
C97686
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
11462853
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
6K8KNJ07D8
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY | |||
|
61670-09-5
Created by
admin on Fri Dec 15 17:35:25 GMT 2023 , Edited by admin on Fri Dec 15 17:35:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD